Disease & disorder
endometrial transitional cell carcinoma
MONDO:0002832
A rare primary carcinoma of the endometrium characterized by the presence of malignant epithelial cells resembling urothelial transitional cells. The malignant transitional cells constitute at least 90% of the tumor cells.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
endometrial transitional cell carcinoma
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
1 shownDrugs being studied
Research locations
AlbuquerqueNew Mexico, United States1AllentownPennsylvania, United States1AnaheimCalifornia, United States1Ann ArborMichigan, United States1AshevilleNorth Carolina, United States1AtlantaGeorgia, United States1AuroraColorado, United States1AventuraFlorida, United States1BakersfieldCalifornia, United States1BaltimoreMaryland, United States1Baton RougeLouisiana, United States1BellevueWashington, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.